Decreased ghrelin-induced GH release in thyrotoxicosis: Comparison with GH-releasing peptide-6 (GHRP-6) and GHRH

Pituitary

Volumn 10, Issue 1, 2007, Pages 27-33

  Nascif, Sergio Oliva ^a   Correa Silva, Silvia Regina ^a   Silva, Marcos Roberto ^a   Lengyel, Ana Maria Judith ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

GH; Ghrelin; GHRH; GHRP 6; Thyrotoxicosis

Indexed keywords

ANTITHYROID AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GHRELIN; GLUCOSE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HISTIDYL DEXTRO TRYPTOPHYLALANYLTRYPTOPHYL DEXTRO PHENYLALANYLLYSINAMIDE; RADIOACTIVE IODINE; THYROID HORMONE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FLUSHING; GLUCOSE BLOOD LEVEL; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HORMONE DETERMINATION; HUMAN; HUNGER; MALE; MONOTHERAPY; NAUSEA; PRIORITY JOURNAL; SIDE EFFECT; THYROTOXICOSIS;

BLOOD GLUCOSE; GHRELIN; GROWTH HORMONE-RELEASING HORMONE; HUMAN GROWTH HORMONE; HUMANS; OLIGOPEPTIDES; THYROTOXICOSIS;

EID: 34147108684     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11102-007-0005-2     Document Type: Article

References (53)

1. Bowers CY, Momany FA, Reynolds GA, Hong A (1984) On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology 114:1537-1545
2. Howard AD, Feighner SD, Cully DF et al (1996) A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273:974-977
3. Arvat E, di Vito L, Maccagno B et al (1997) Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effects of GHRH, TRH and hCRH. Peptides 18:885-891
4. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K (1999) Ghrelin is a growth hormone-releasing hormone acylated peptide from stomach. Nature 402:656-660
5. Gnanapavan S, Kola B, Bustin SA et al (2002) The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 87:2988-2991
6. van der Lely AJ, Tschop M, Heiman ML, Ghigo E (2004) Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 25:426-457
7. Banks WA, Tschop M, Robinson SM, Heiman ML (2002) Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J Pharmacol Exp Ther 302:822-827
8. Takaya K, Ariyasu H, Kanamoto N et al (2000) Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Metab 85:4908-4911
9. Peino R, Baldelli R, Rodriguez-Garcia J et al (2000) Ghrelin-induced growth hormone secretion in humans. Eur J Endocrinol 143:11-14
10. Arvat E, Maccario M, Di Vito L et al (2001) Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. J Clin Endocrinol Metab 86:1169-1174
11. Popovic V, Damjanovic S, Micic D, Djurovic M, Dieguez C, Casanueva FF (1995) Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: Evidence that GHRP-6 main action is exerted at the hypothalamic level. J Clin Endocrinol Metab 80:942-947
12. Popovic V, Miljic D, Micic D et al (2003) Ghrelin main action on the regulation of growth hormone release is exerted at hypothalamic level. J Clin Endocrinol Metab 88:3450-3453
13. Goth MI, Lyons CE, Canny BJ, Thorner MO (1992) Pituitary adenylate cyclase activating polypeptide, growth hormone (GH)-releasing peptide and GH-releasing hormone stimulate GH release through distinct pituitary receptors. Endocrinology 130:939-944
14. Chen C, Wu D, Clarke IJ (1996) Signal transduction systems employed by synthetic GH-releasing peptides in somatotrophs. J Endocrinol 148:381-386
15. Smith RG, Van der Ploeg LH, Howard AD et al (1997) Peptidomimetic regulation of growth hormone secretion. Endocr Rev 18:621-645
16. Tannenbaum GS, Bowers CY (2001) Interactions of growth hormone secretagogues and growth hormone-releasing hormone/somatostatin. Endocrine 14:21-27
17. Broglio F, Arvat E, Benso A et al (2001) Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J Clin Endocrinol Metab 86:5083-5086
18. Gauna C, Delhanty PJ, Hofland LJ et al (2005) Ghrelin stimulates, whereas des-octanoyl ghrelin inhibits, glucose output by primary hepatocytes. J Clin Endocrinol Metab 90:1055-1060
19. Broglio F, Gottero C, Prodam F et al (2004) Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans. J Clin Endocrinol Metab 89:3062-3065
20. Dieguez C, Foord SM, Peters JR, Hall R, Scanlon MF (1985) The effects of thyroid hormone deprivation in vivo and in vitro on growth hormone (GH) responses to human pancreatic (tumor) GH-releasing factor (1-40) by dispersed rat anterior pituitary cells. Endocrinology 116:1066-1070
21. Jones PM, Burrin JM, Ghatei MA, O'Halloran DJ, Legon S, Bloom SR (1990) The influence of thyroid hormone status on the hypothalamo-hypophyseal growth hormone axis. Endocrinology 126:1374-1379
22. Valcavi R, Zini M, Portioli I (1992) Thyroid hormones and growth hormone secretion. J Endocrinol Invest 15:313-330
23. Giustina A, Wehrenberg WB (1995) Influence of thyroid hormones on the regulation of growth hormone secretion. Eur J Endocrinol 133:646-653
24. Burgess JA, Smith BR, Merimee TJ (1966) Growth hormone in thyrotoxicosis: Effect of insulin-induced hypoglycemia. J Clin Endocrinol Metab 26:1257-1260
25. Giustina A, Buffoli MG, Bussi AR, Wehrenberg WB (1991) Acute effects of clonidine and growth-hormone-releasing hormone on growth hormone secretion in patients with hyperthyroidism. Horm Res 36:192-195
26. Valcavi R, Dieguez C, Zini M, Muruais C, Casanueva F, Portioli I (1993) Influence of hyperthyroidism on growth hormone secretion. Clin Endocrinol 38:515-522
27. Ramos-Dias JC, Yateman M, Camacho-Hübner C, Grossman A, Lengyel AMJ (1995) Low circulating IGF-I levels in hyperthyroidism are associated with decreased GH response to GH-releasing hormone. Clin Endocrinol 43:583-589
28. Ramos-Dias JC, Pimentel-Filho F, Reis AF, Lengyel AMJ (1996) Different growth hormone (GH) responses to GH-releasing peptide and GH-releasing hormone in hyperthyroidism. J Clin Endocrinol Metab 81:1343-1346
29. Yeung RTT (1973) Effect of propranolol on plasma growth hormone response in insulin-induced hypoglycemia in thyrotoxic patients. J Clin Endocrinol Metab 37:968-971
30. Valcavi R, Dieguez C, Zini M et al (1991) Effect of pyridostigmine and pirenzepine on GH responses to GHRH in hyperthyroid patients. Clin Endocrinol 35:141-144
31. Iranmanesh A, Lizarralde G, Johnson ML, Veldhuis JD (1991) Nature of altered growth hormone secretion in hyperthyroidism. J Clin Endocrinol Metab 72:108-115
32. Kamegai J, Tamura H, Shimizu T et al (2004) The role of pituitary ghrelin in growth hormone (GH) secretion: GH-releasing hormone-dependent regulation of pituitary ghrelin gene expression and peptide content. Endocrinology 145:3731-3738
33. Caminos JE, Seoane LM, Tovar SA, Casanueva FF, Dieguez C (2002) Influence of thyroid status and growth hormone deficiency on ghrelin. Eur J Endocrinol 147:159-163
34. Riis ALD, Hansen TK, Moller N, Weeke J, Jorgensen JOL (2003) Hyperthyroidism is associated with suppressed circulating ghrelin levels. J Clin Endocrinol Metab 88:853-857
35. Rojdmark S, Calissendorff J, Danielsson O, Brismar K (2005) Hunger-satiety signals in patients with Graves' thyrotoxicosis before, during, and after long-term pharmacological treatment. Endocrine 27:55-61
36. Muccioli G, Papotti M, Locatelli V, Ghigo E, Deghenghi R (2001) Binding of 125I-labeled ghrelin to membranes from human hypothalamus and pituitary gland. J Endocrinol Invest 24:7-9
37. Arvat E, Gianotti L, Grottoli S et al (1994) Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects. J Clin Endocrinol Metab 79:1440-1443
38. Cordido F, Penalva A, Dieguez C, Casanueva FF (1993) Massive growth hormone (GH)discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: Evidence for a marked somatotroph secretory capability in obesity. J Clin Endocrinol Metab 76:819-823
39. Johnson EO, Kamilaris TC, Calogero AE, Gold PW, Chrousos GP (2005) Experimentally-induced hyperthyroidism is associated with activation of the rat hypothalamic-pituitary-adrenal axis. Eur J Endocrinol 153:177-185
40. Tsushima T, Katoh Y, Miyachi Y et al (1999) Serum concentration of 20K human growth hormone (20K hGH) measured by a specific enzyme-linked immunosorbent assay. Study Group of 20K hGH. J Clin Endocrinol Metab 84:317-322
41. 183HIS (R183H) GH-I gene mutation. Clin Chem 49:1002-1005
42. Popovic V, Miljic D, Pekic S et al (2005) Low plasma ghrelin level in gastrectomized patients is accompanied by enhanced sensitivity to the ghrelin-induced growth hormone release. J Clin Endocrinol Metab 90:2187-2191
43. Pandya N, DeMott-Friberg R, Bowers CY, Barkan AL, Jaffe CA (1998) Growth hormone (GH)-releasing peptide-6 requires endogenous hypothalamic GH-releasing hormone for maximal GH stimulation. J Clin Endocrinol Metab 83:1186-1189
44. Korbonits M, Goldstone AP, Gueorguiev M, Grossman AB (2004) Ghrelin - a hormone with multiple functions. Front Neuroendocrinol 25:27-68
45. Malagón MM, Luque RM, Ruiz-Guerrero E et al (2003) Intracellular signaling mechanisms mediating ghrelin-stimulated growth hormone release in somatotropes. Endocrinology 144:5372-5380
46. Petersenn S, Rasch AC, Penshorn M, Beil FU, Schulte HM (2001) Genomic structure and transcriptional regulation of the human growth hormone secretagogue receptor. Endocrinology 142:2649-2659
47. Leal-Cerro A, Torres E, Soto A et al (2002) Ghrelin is no longer able to stimulate growth hormone secretion in patients with Cushing's syndrome but instead induces exaggerated corticotropin and cortisol responses. Neuroendocrinology 76:390-396
48. Giordano R, Picu A, Pagotto U et al (2005) The negative association between total ghrelin levels, body mass and insulin secretion is lost in hypercortisolemic patients with Cushing's disease. Eur J Endocrinol 153:535-543
49. Kaji H, Kishimoto M, Kirimura T et al (2001) Hormonal regulation of the human ghrelin receptor gene transcription. Biochem Biophys Res Commun 284:660-666
50. Ramos-Dias JC, Lengyel AM (1999) Iopanoic acid-induced decrease of circulating T3 causes a significant increase in GH responsiveness to GH releasing hormone in thyrotoxic patients. Clin Endocrinol 51:461-467
51. Borges JL, Blizzard RM, Gelato MC et al (1983) Effects of human pancreatic tumour growth hormone releasing factor on growth hormone and somatomedin C levels in patients with idiopathic growth hormone deficiency. Lancet 2:119-124
52. Gauna C, Meyler FM, Janssen JAMLJ et al (2004) Administration of acylated ghrelin reduces insulin sensitivity, whereas the combination of acylated plus unacylated ghrelin strongly improves insulin sensitivity. J Clin Endocrinol Metab 89:5035-5042
53. Muller AF, Janssen JA, Hofland LJ et al (2001) Blockade of the growth hormone (GH) receptor unmasks rapid GH-releasing peptide-6-mediated tissue-specific insulin resistance. J Clin Endocrinol Metab 86:590-593